Your browser doesn't support javascript.
loading
De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia.
Rees, Elliott; Han, Jun; Morgan, Joanne; Carrera, Noa; Escott-Price, Valentina; Pocklington, Andrew J; Duffield, Madeleine; Hall, Lynsey S; Legge, Sophie E; Pardiñas, Antonio F; Richards, Alexander L; Roth, Julian; Lezheiko, Tatyana; Kondratyev, Nikolay; Kaleda, Vasilii; Golimbet, Vera; Parellada, Mara; González-Peñas, Javier; Arango, Celso; Gawlik, Micha; Kirov, George; Walters, James T R; Holmans, Peter; O'Donovan, Michael C; Owen, Michael J.
Afiliação
  • Rees E; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Han J; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Morgan J; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Carrera N; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Escott-Price V; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Pocklington AJ; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Duffield M; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Hall LS; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Legge SE; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Pardiñas AF; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Richards AL; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Roth J; Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany.
  • Lezheiko T; Clinical Genetics Laboratory, Mental Health Research Centre, Moscow, Russia.
  • Kondratyev N; Clinical Genetics Laboratory, Mental Health Research Centre, Moscow, Russia.
  • Kaleda V; Clinical Genetics Laboratory, Mental Health Research Centre, Moscow, Russia.
  • Golimbet V; Clinical Genetics Laboratory, Mental Health Research Centre, Moscow, Russia.
  • Parellada M; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, IisGM, School of Medicine, Universidad Complutense, CIBERSAM, Madrid, Spain.
  • González-Peñas J; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, IisGM, School of Medicine, Universidad Complutense, CIBERSAM, Madrid, Spain.
  • Arango C; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, IisGM, School of Medicine, Universidad Complutense, CIBERSAM, Madrid, Spain.
  • Gawlik M; Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany.
  • Kirov G; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Walters JTR; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Holmans P; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • O'Donovan MC; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK. odonovanmc@cardiff.ac.uk.
  • Owen MJ; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK. owenmj@cardiff.ac.uk.
Nat Neurosci ; 23(2): 179-184, 2020 02.
Article em En | MEDLINE | ID: mdl-31932766
Schizophrenia is a highly polygenic disorder with important contributions from both common and rare risk alleles. We analyzed exome sequencing data for de novo variants (DNVs) in a new sample of 613 schizophrenia trios and combined this with published data to give a total of 3,444 trios. In this new data, loss-of-function (LoF) DNVs were significantly enriched among 3,471 LoF-intolerant genes, which supports previous findings. In the full dataset, genes associated with neurodevelopmental disorders (n = 159) were significantly enriched for LoF DNVs. Within these neurodevelopmental disorder genes, SLC6A1, which encodes a γ-aminobutyric acid transporter, was associated with missense-damaging DNVs. In 1,122 trios for which genome-wide common variant data were available, schizophrenia and bipolar disorder polygenic risk were significantly overtransmitted to probands. Probands carrying LoF or deletion DNVs in LoF-intolerant or neurodevelopmental disorder genes had significantly less overtransmission of schizophrenia polygenic risk than did non-carriers, which provides a second robust line of evidence that these DNVs increase liability to schizophrenia.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Predisposição Genética para Doença / Proteínas da Membrana Plasmática de Transporte de GABA Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Predisposição Genética para Doença / Proteínas da Membrana Plasmática de Transporte de GABA Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article